Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma

Neuropathology. 2017 Feb;37(1):58-63. doi: 10.1111/neup.12318. Epub 2016 Jun 15.

Abstract

Epithelioid glioblastoma (E-GBM) is a rare variant of glioblastoma (GBM), characterized by epithelioid cells with eosinophilic round cytoplasm devoid of stellate cytoplasmic processes. A number of studies have demonstrated that more than half of E-GBMs harbor a valine to glutamic acid substitution at position 600 of the serine/threonine-protein kinase BRAF (BRAF V600E). However, there are no previous reports on E-GBM with telomerase reverse transcriptase (TERT) promoter mutation in addition to BRAF V600E mutation. Here, we report an E-GBM case in an 18-year-old man with BRAF V600E and TERT promoter mutations. The tumor composed of 80% E-GBM and 20% diffuse astrocytoma-like components, and BRAF V600E and TERT promoter mutations were detected in both. E-GBM generally arises as a primary lesion; however, a few previous cases have been demonstrated to accompany low-grade areas. Demonstration of concurrent BRAF V600E and TERT promoter mutations in low- and high-grade lesions strongly suggested their identical origin, and acquisition of each mutation may be an early event, possibly playing a pivotal role in the genesis and subsequent progression to E-GBM.

Keywords: BRAF; TERT promoter; epithelioid glioblastoma; low-grade astrocytoma; tumorigenesis.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Astrocytoma / diagnostic imaging
  • Astrocytoma / genetics*
  • Astrocytoma / pathology
  • Astrocytoma / therapy
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy
  • Cranial Irradiation
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / therapeutic use
  • Fatal Outcome
  • Glioblastoma / diagnostic imaging
  • Glioblastoma / genetics*
  • Glioblastoma / pathology
  • Glioblastoma / therapy
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mutation*
  • Neoplasms, Multiple Primary / diagnostic imaging
  • Neoplasms, Multiple Primary / genetics*
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / therapy
  • Neurosurgical Procedures
  • Promoter Regions, Genetic*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Telomerase / genetics*
  • Temozolomide
  • Temporal Lobe / diagnostic imaging*
  • Temporal Lobe / pathology*
  • Temporal Lobe / surgery

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Proto-Oncogene Proteins B-raf
  • Telomerase
  • Temozolomide